Therapeutic Goods Act 1989
I, MICHAEL DODSON, Director, Non-Prescription Medicines Branch, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing for the purposes of section 42 DK (I) of the Therapeutic Goods Act, give notice that the restricted representations described in paragraph (a) below, being representations that are necessary for the appropriate use ofthe therapeutic goods described in paragraph (b) below, may be included either on the label ofthe package ofthose goods or in information included in the package in which those goods are contained:
- representations to the effect that the goods described in paragraph (b) below may be used "For the treatment of patients with known cardiovascular or cerebrovascular disease, as an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)" and "Reduces the risk of heart attack and stroke in patients with known cardiovascular or cerebrovascular disease".
- TERRY WHITE CHEMISTS EC ASPIRIN 100 aspirin 100mg tablet blister pack
- supplied as an over-the-counter drug by Symbion Pharmacy Services Pty Lt.
Dated this 12th day of June 2010.
MICHAEL DODSON
Delegate ofthe Secretary to the Department of Health and Ageing